Pacira BioSciences (PCRX) Interest & Investment Income (2010 - 2026)

Pacira BioSciences has reported Interest & Investment Income for 17 years, with the latest figure at $1.9 million in Q2 2026.

• On a quarterly basis, Interest & Investment Income fell 61.18% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $14.7 million, a 35.91% decrease from a year earlier, with the FY2025 full-year figure at $22.7 million, up 15.46% from the prior year.
• Interest & Investment Income was $1.9 million for Q2 2026 at Pacira BioSciences, up from $1.9 million in the prior quarter.
• The five-year high for Interest & Investment Income was $8.5 million in Q3 2025, with the low at $252000.0 in Q2 2022.
• Average Interest & Investment Income over 5 years is $3.5 million, with a median of $3.0 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Interest & Investment Income jumped 3381.25% in 2022, then tumbled 72.01% in 2026.
• Over 5 years, Interest & Investment Income stood at $2.8 million in 2022, then advanced by 22.98% to $3.4 million in 2023, then surged by 62.19% to $5.6 million in 2024, then tumbled by 58.69% to $2.3 million in 2025, then slipped by 15.29% to $1.9 million in 2026.
• The last three Interest & Investment Income figures came in at $1.9 million (Q2 2026), $1.9 million (Q1 2026), and $2.3 million (Q4 2025), per Business Quant data.